Director/PDMR Shareholding

RNS Number : 7966E

GlaxoSmithKline PLC

12 April 2011

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares at a price of £12.22 per share and ADRs at a price of $39.96 per ADR following the notional re-investment of the dividend paid to shareholders on 7 April 2011.

	Ordinary shares	ADRs
Mr A P Witty	14,586.55
Dr M M Slaoui		3,232.51
Mr S M Bicknell	1,095.91
Mr J M Clarke	3,300.39
Mrs D P Connelly		2,284.17
Mr M Dunoyer	1,578.62
Mr E J Gray	2,376.38
Mr S A Hussain	3,264.99
Mr W C Louv		997.91
Dr D Pulman		1,589.94
Mr D S Redfern	1,324.87
Mr J R Stéphenne	1,967.86
Ms C Thomas	1,949.85
Mr D E Troy		2,071.71
Dr P J T Vallance	1,213.62
Mrs V A Whyte	100.64

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

12 April 2011

 

END

 

 

RDSQLLFFFZFEBBV